Drugs / Wenyang Tongbi Granules
Wenyang Tongbi Granules
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07626528 | Jul 2026 → Dec 2027 expected | chemotherapy-induced neuropathy | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wenyang Tongbi Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07626528 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Wenyang Tongbi Granules (a patented Traditional Chinese Medicine prescription)” NCT07626528 ↗ |